Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
about
p53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum ConceptEndometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.Intensified surveillance for early detection of breast cancer in high-risk patientsBreast liposarcoma with solitary metastasis to the pleura: A case report.Whole genome sequence analysis suggests intratumoral heterogeneity in dissemination of breast cancer to lymph nodesConcise review: hematopoietic stem cell aging and the prospects for rejuvenationLobular breast cancer: incidence and genetic and non-genetic risk factors.Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese populationPrimed for cancer: Li Fraumeni Syndrome and the pre-cancerous nicheA mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.Recent developments in brain tumor predisposing syndromes.DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations.Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma.Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyondLi-Fraumeni SyndromeTHE GORDON WILSON LECTURE EVOLUTION OF CLINICAL CANCER GENETICS.Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer.TP53 mutations in human cancer: database reassessment and prospects for the next decade.Recommendations for analyzing and reporting TP53 gene variants in the high-throughput sequencing era.The TP53 gene network in a postgenomic era.Lung Adenocarcinoma as Part of the Li-Fraumeni Syndrome Spectrum: Preliminary Data of the LIFSCREEN Randomized Clinical Trial.Genetic predisposition to hematologic malignancies: management and surveillance.Should Genetic Testing be Offered for Children? The Perspectives of Adolescents and Emerging Adults in Families with Li-Fraumeni Syndrome.Next generation sequencing is informing phenotype: a TP53 example.Advances in Hereditary Colorectal and Pancreatic Cancers.Tumor-Suppressor Functions of the TP53 Pathway.Clinical Outcomes of TP53 Mutations in Cancers.Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome.Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni Syndrome.Puzzles in modern biology. III.Two kinds of causality in age-related disease.Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing.TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome.Importance of updating family cancer history in childhood cancer survivors.Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.Gestational choriocarcinoma associated with a germline TP53 mutation.Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.Pleomorphic myxoid liposarcoma in an adolescent with Li-Fraumeni syndrome.
P2860
Q28079390-5024221F-E091-43C4-A08F-174755E5ACDCQ30234614-83A524F5-E96F-436B-AFEC-461C96F5C900Q30392157-368DA9DB-DA46-4E65-90CA-32DA51E44525Q33885787-C9F196BC-9F30-4CB8-A50D-D7DFA040C001Q34784863-0E8FCCA5-DC24-4EC9-B33B-58A3907A8C06Q35001363-E8816732-C220-4219-8E02-EAABDA067034Q35170028-2F5127C2-5AB4-4C2D-8C4C-9ECCCFCB894FQ35632374-0C4E7FD2-F7C0-4FE8-BA57-3C5A4F5D34D3Q35717532-F9D8744F-E8FF-408F-B885-120C8449BA81Q35786931-821FB120-4254-4DFF-945E-FAB959C13771Q35860402-DA52A57A-CD8A-40BF-9C73-7D0583223784Q35881338-1FADF364-11AA-44EA-BE8C-A940B9C26191Q36169808-2052B608-0465-449F-B070-473284A00CB2Q36619933-A54290C9-1584-4A1F-8179-0FED0542A212Q37032644-BD0AF608-469E-494E-9E15-828F85B181ADQ37563869-B1220E19-3D4B-4F83-916F-5F81ED1B0731Q37651932-720C541D-0A8C-4BDF-BBDA-5585095AC0BDQ38199075-B668333E-A398-436F-9B56-11CDF41693C3Q38204360-3F7D485A-BBA2-42AC-A107-3ADCE99ABFD9Q38206172-AE60FE32-EFB3-4664-A07F-7BEE97481B67Q38643814-608E5BCD-514B-4583-A6F0-643B251C5633Q38733102-71C33FBF-E403-408E-BA58-69BBB07AC788Q38743800-887F3BFF-433B-4F94-A9DB-A6EA1C07DAFBQ38783154-5132878F-9865-4135-99BD-6E40566BB7F8Q38798530-B1251B1A-16C2-411F-9BBE-37F7DA5C54E1Q38824332-83D4BE7F-23DD-4F27-B7C5-8F10A7F1EBE3Q38906201-60345005-D02C-4E92-B177-2BA3C8B7FAC9Q39004018-2DE914C8-6D02-4956-9E4A-51FA7D878D81Q39041480-6556879F-7D51-4AFC-87F3-68A124A7BDC9Q39284496-DE6FB6D0-B31C-473B-834E-6EF95BBF5836Q40339155-EAF8FD8C-2D6E-4CB9-92C7-349BC75BE43AQ40445128-70218594-B534-480D-A569-3AF92788026CQ41733541-22CBDCC3-D9FA-43FB-9396-29DBA980B4A4Q42775929-F2754253-DB67-4B92-8752-57A892D27C92Q44931397-FF1AE5EE-3475-400D-810D-B7CCEE3315C4Q47369258-98255289-B96C-4392-B830-C027251358AFQ47564553-A6102D1B-DB43-4D79-A13A-12BF462F3B53Q47772572-35CDAF49-73AE-4F46-B7EE-95B6126F8632Q47801891-4311BF11-6A57-4E30-BE4B-B2C9E2F216AEQ47870586-526D64E4-E073-47AF-9B30-3B1F9DD38A37
P2860
Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
@en
type
label
Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
@en
prefLabel
Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
@en
P2860
P356
P1433
P1476
Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
@en
P2093
Judy E Garber
Junne Kamihara
P2860
P304
P356
10.1002/HUMU.22559
P50
P577
2014-06-01T00:00:00Z